271. Ankylosing spondylitis Clinical trials / Disease details

Clinical trials : 563 / Drugs : 372 - (DrugBank : 72) / Drug target genes : 41 - Drug target pathways : 145

28 trials found

diseases per page:

Showing 1 to 10 of 28 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-002061-54-IT (EUCTR)	13/10/2016	15/11/2018	Switch between originator infliximab (Remicade®) and biosimilar infliximab (Remsima®) in the treatme ...	Switch between originator infliximab (Remicade®) and biosimilar infliximab (Remsima®) in the treatme ...	Rheumatoid arthritis, seronegative spondylo arthritis,Crohn's Disease, Ulcerative Colitis MedDRA ver ...	Trade Name: REMSIMA- 100 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - F ...	UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI	NULL	Not Recruiting			Female: yes Male: yes	250	Phase 4	Italy
2	NCT02762812 (ClinicalTrials.gov)	January 2016	4/4/2016	Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With ...	International Multi-center Comparative Double-blind Randomized Clinical Trial to Evaluate Efficacy a ...	Ankylosing Spondylitis	Biological: BCD-055;Biological: Remicade ®	Biocad	NULL	Completed	18 Years	65 Years	All	199	Phase 3	Russian Federation
3	EUCTR2015-002284-42-FI (EUCTR)	18/09/2015	28/08/2015	The rationale for this study is to gain insight in the extent and impact of immunogenicityof TNF inh ...	INTENT: immunogenicity in patients failing response on anti-TNF-Immunogenicity and pharmacokinetics ...	rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis.;Therapeutic area: N ...	Trade Name: Enbrel Product Name: etanercept Trade Name: Humira Product Name: adalimumab Trade Name: Cimz ...	READE	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1650	Phase 1	Finland
4	NCT02605642 (ClinicalTrials.gov)	September 10, 2015	2/9/2015	Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who ...	PERSIST: PROSPECTIVE OBSERVATIONAL COHORT STUDY TO ASSESS PERSISTENCE OF CT-P13 (INFLIXIMAB) IN PATI ...	Rheumatoid Diseases;Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis	Drug: CT-P13	Pfizer	Hospira, now a wholly owned subsidiary of Pfizer	Completed	18 Years	N/A	All	351		Bulgaria;Canada;Czechia;Germany;Greece;Spain;United Kingdom;Czech Republic;France;Italy
5	NCT02359903 (ClinicalTrials.gov)	February 2015	30/1/2015	Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicadein Patients With Ankylo ...	International Multicenter Comparative Double Blind Study of Pharmacokinetics and Safety of BCD-055 a ...	Ankylosing Spondylitis	Drug: Infliximab (BCD-055);Drug: Infliximab (Remicade)	Biocad	NULL	Completed	18 Years	65 Years	All	90	Phase 1	Belarus;Russian Federation
6	EUCTR2014-002056-40-NO (EUCTR)	12/08/2014	13/06/2014	A study to evaluate the safety and efficacy of switching from regular infliximab to biosimilar infli ...	A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF SWITCHING FR ...	Rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn’s disease an ...	Trade Name: Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning Trade Name: Remsima 10 ...	Diakonhjemmet Hospital AS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Norway
7	NCT01571206 (ClinicalTrials.gov)	March 2012	23/3/2012	An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Pati ...	An Open-Label, Single-Arm, Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 in ...	Ankylosing Spondylitis	Biological: Infliximab	Celltrion	NULL	Completed	18 Years	75 Years	Both	174	Phase 1	Korea, Republic of
8	NCT01148901 (ClinicalTrials.gov)	June 2010	21/6/2010	Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylo ...	Hip Arthritis Associated With AS Efficacy and Safety of Early Treatment With Infliximab (Remicade®)	Ankylosing Spondylitis	Drug: Infliximab	Merck Sharp & Dohme Corp.	Hospital Universitario Reina Sofia;Dr. Jose María Martos Becerra (Central Radiological Assessment) – ...	Withdrawn	18 Years	N/A	Both	0	Phase 4	Spain
9	EUCTR2009-016587-36-ES (EUCTR)	15/03/2010	27/01/2010	Artritis de cadera asociada a la EA. Eficacia y Seguridad del tratamiento precoz con Infliximab (Rem ...	Artritis de cadera asociada a la EA. Eficacia y Seguridad del tratamiento precoz con Infliximab (Rem ...	Espondilitis anquilosante MedDRA version: 12.1;Level: LLT;Classification code 10002556;Term: Ankylos ...	Trade Name: REMICADE 100 mg polvo para concentrado para solución para perfusión INN or Proposed INN: I ...	Schering Plough, S.A	NULL	Not Recruiting			Female: yes Male: yes	70		Spain
10	EUCTR2006-001579-40-DK (EUCTR)	16/04/2008	04/09/2007	Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with in ...	Study of peripheral enthesitis with ultrasonography doppler in spondyloarthropathies treated with in ...	Spondyloarthropathies MedDRA version: 9.1;Level: LLT;Classification code 10002556;Term: Ankylosing s ...	Trade Name: Remicade INN or Proposed INN: infliximab	Schering-Plough France	NULL	Not Recruiting			Female: yes Male: yes	120		France;Hungary;Spain;Denmark

First Previous1 2 3Next Last